Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.15
+0.07 (0.50%)
At close: Aug 26, 2026, 4:00 PM EDT
14.15
0.00 (0.00%)
After-hours: Aug 26, 2026, 7:30 PM EDT
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $412.12 million as of August 26, 2026. Its market cap has increased by 122.65% in one year.
Market Cap
412.12M
Enterprise Value
382.67M
1-Year Change
122.65%
Ranking
Category
Stock Price
$14.15
ChartMarket Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $412.12M, an increase of 42.46%. That is a compound annual growth rate of 2.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 412.10M | -9.47% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 434.23M |
| EyePoint | 431.49M |
| vTv Therapeutics | 421.32M |
| Lexeo Therapeutics | 420.88M |
| Rocket Pharmaceuticals | 414.95M |
| X4 Pharmaceuticals | 412.45M |
| Fennec Pharmaceuticals | 410.64M |
| Foghorn Therapeutics | 406.79M |